Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ofelia Noceti"'
Publikováno v:
Revista Médica del Uruguay, Vol 33, Iss 3, Pp 195-206 (2019)
En los últimos diez años, en esta era posantibiótica, la colistina ha resurgido como un último recurso frente a infecciones por patógenos como Pseudomonas aeruginosa, Acinetobacter baumannii complex y enterobacterias productoras de carbapenemasa
Externí odkaz:
https://doaj.org/article/81c39dfa4d5e4cb9899e1f47a2e6d2d4
Autor:
Victoria Mainardi, Josemaría Menéndez, Marcelo Valverde, Gonzalo San Martín, Jimena Prieto, Ofelia Noceti, Germán Botto, Julio Medina, Paula Martínez, Claudia Montaño, Jorge Castelli, Iliana Pedemonte, Alejo Gestal, Felipe Adler, Martín Elizondo, Patricio Vanerio, Victorio Cervera, Sara González, Martín Harguindeguy, Alejandro Leites, Solange Gerona
Publikováno v:
Revista Médica del Uruguay, Vol 36, Iss 4 (2020)
Introducción: el trasplante hepático (TH) constituye el tratamiento de elección en pacientes con enfermedades hepáticas severas e irreversibles, sin opción de tratamientos alternativos eficaces. La medición de indicadores de calidad permite det
Externí odkaz:
https://doaj.org/article/ebcfce87427b4ccc99f9435cde021e33
Publikováno v:
Archives of virology. 167(12)
Hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide. Hepatitis E is an enterically transmitted zoonotic disease that causes large waterborne epidemic outbreaks in developing countries and has become an increasing public-health con
Autor:
Parag Chatterjee, Josemaria Menendez, Ofelia Noceti, Solange Gerona, Melina Toribio, Leandro J. Cymberknop, Ricardo L. Armentano
Publikováno v:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2021
Liver transplantation is the last therapeutic option in patients with end-stage liver diseases. The adequate clinical management of transplant-patients impacts their vital prognosis and decisions on many occasions are made from the interaction of mul
Autor:
G. Anuradha, Ricardo L. Armentano, Gopal Krishna Basak, Anu Mary Chacko, Parag Chatterjee, Asmita Chotani, Leandro J. Cymberknop, Archana Gahiwad, Solange Gerona, Kuntal Ghosh, Jimmy Xiangji Huang, Mobarakol Islam, Rakshit Jain, Sreenivasan M., Arpan Kumar Maiti, Josemaría Menéndez, Soumik Mitra, Ofelia Noceti, Navid Panchi, M. Parimala, G Thippa Reddy, Hongliang Ren, Sandipa Roy, Sanjiban Sekhar Roy, Parita Sanghani, Prem Kumar Singh, Kathiravan Srinivasan, Y.-H. Taguchi, Melina Toribio, B.K. Tripathy, Xinhui Tu, Pratima Upretee, Anmol Wadhwa, Hsiuying Wang, Francis Wong, Mengya Xu, Mehmet Emin Yüksel, Azadeh Zamanifar, Runjie Zhu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac33a9290a325a776be4692ab4fde352
https://doi.org/10.1016/b978-0-12-819314-3.09992-4
https://doi.org/10.1016/b978-0-12-819314-3.09992-4
Autor:
Mercè Brunet, Eberhard Wieland, Alexander A. Vinks, Pierre Wallemacq, Nils Tore Vethe, Nicolas Picard, Dirk Jan A.R. Moes, Mariadelfina Molinaro, Paweł K. Kunicki, Klemens Budde, Satohiro Masuda, Maja Theresa Dieterlen, Tomoyuki Mizuno, Stein Bergan, Laure Elens, Anders Åsberg, Olga Millán, Florian Lemaitre, Burkhard Tönshoff, Maria Shipkova, Jesse J. Swen, Teun van Gelder, Tomasz Pawinski, Vincent Haufroid, Ofelia Noceti, Tom C. Zwart, Pierre Marquet, Smita Pattanaik, Jean-Baptiste Woillard, Loralie J. Langman, Markus J. Barten, Dennis A. Hesselink, Ron H.N. van Schaik, Michael Oellerich, Christoph Seger, Linda Salzmann, Kamisha L. Johnson-Davis, Raman Venkataramanan
Publikováno v:
Therapeutic Drug Monitoring, Vol. 43, no.2, p. 150-200 (2021)
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 43(2), 150-200. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 43(2), 150-200. LIPPINCOTT WILLIAMS & WILKINS
When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy, fixed doses were recommended by the manufacturer. Awareness of the potential for a more personalized dosing has led to development of methods to estimate MPA area und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b1cf2bb23290633f56b83d70251d51
https://hdl.handle.net/2078.1/249100
https://hdl.handle.net/2078.1/249100
Autor:
Ricardo L. Armentano, Parag Chatterjee, Josemaría Menéndez, Leandro J. Cymberknop, Melina Toribio, Ofelia Noceti, Solange Gerona, Natalia Harguindeguy
Publikováno v:
2019 IEEE 9th International Conference on Advanced Computing (IACC)
IEEE Xplore
REDI
Agencia Nacional de Investigación e Innovación
instacron:Agencia Nacional de Investigación e Innovación
IEEE Xplore
REDI
Agencia Nacional de Investigación e Innovación
instacron:Agencia Nacional de Investigación e Innovación
Recent years have seen a phenomenal change in healthcare paradigms and data analytics clubbed with computational intelligence has been a key player in this field. One of the main objectives of incorporating computational intelligence in healthcare an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f64066e286f4244204edb88f4e599e3
https://ieeexplore.ieee.org/document/8971514
https://ieeexplore.ieee.org/document/8971514
Autor:
Josemaría Menéndez, Parag Chatterjee, Melina Toribio, Ricardo L. Armentano, Leandro J. Cymberknop, Ofelia Noceti, Solange Gerona
Publikováno v:
Data Analytics in Biomedical Engineering and Healthcare
REDI
Agencia Nacional de Investigación e Innovación
instacron:Agencia Nacional de Investigación e Innovación
REDI
Agencia Nacional de Investigación e Innovación
instacron:Agencia Nacional de Investigación e Innovación
Healthcare paradigms have always focused into the domain of early prediction of diseases. Especially in field of chronic diseases, the spotlight is always on the aspect of early detection and prevention by controlling the key risk factors in a compre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4c05447d4cb961733b0103f3773ccd4
https://www.sciencedirect.com/science/article/pii/B9780128193143000045
https://www.sciencedirect.com/science/article/pii/B9780128193143000045
Autor:
Jean-Baptiste Woillard, Uwe Christians, Dirk Jan A.R. Moes, Claudia Sommerer, Nicolas Picard, Tomasz Pawinski, Brenda C. M. de Winter, Markus J. Barten, Tomoyuki Mizuno, Pierre Wallemacq, Florian Lemaitre, Kamisha L. Johnson-Davis, Nils Tore Vethe, Pierre Marquet, Binu S. Mathew, Ron H.N. van Schaik, Iain MacPhee, Loralie J. Langman, Dennis A. Hesselink, Christoph Seger, Teun van Gelder, Alexander A. Vinks, Paweł K. Kunicki, Vincent Haufroid, Stein Bergan, Klemens Budde, Satohiro Masuda, Mercè Brunet, Eberhard Wieland, Caroline Monchaud, Helena Colom, Maria Shipkova, Ofelia Noceti, Laure Elens, Olga Millán, Maja Theresa Dieterlen, Anders Åsberg
Publikováno v:
Therapeutic Drug Monitoring, 41(3), 261-307. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic Drug Monitoring, 41(3), 261-307
Therapeutic Drug Monitoring, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic drug monitoring, Vol. 41, no.3, p. 261-307 (2019)
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic Drug Monitoring, 41(3), 261-307
Therapeutic Drug Monitoring, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic drug monitoring, Vol. 41, no.3, p. 261-307 (2019)
International audience; Ten years ago, a consensus report on the optimization of tacrolimus was published in this journal. In 2017, the Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9f00168e1d0fa4d232dd8058bcdc16
https://pure.eur.nl/en/publications/111d5c63-b5aa-483e-a2b6-ea778ee98946
https://pure.eur.nl/en/publications/111d5c63-b5aa-483e-a2b6-ea778ee98946
Autor:
Teun van Gelder, Vincent Haufroid, Mercè Brunet, Eberhard Wieland, Michael Oellerich, Claudia Sommerer, Marcos López-Hoyos, Tomasz Pawinski, Pierre Wallemacq, Nicolas Picard, Olga López, D. A. Hesselink, Maria Shipkova, Uwe Christians, Markus J. Barten, Ofelia Noceti, P. Marquet, Klemens Budde, Stein Bergan
Publikováno v:
EUR Research Portal
Therapeutic Drug Monitoring, 38, S1-S20. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring, 38, S1-S20. Lippincott Williams & Wilkins
With current treatment regimens, a relatively high proportion of transplant recipients experience underimmunosuppression or overimmunosuppression. Recently, several promising biomarkers have been identified for determining patient alloreactivity, whi